The lawsuit claims that Celsius Holdings failed to properly disclose cardiac risks linked to Alani Nu beverages. Furthermore, the complaint alleges the company actively marketed these high-caffeine products to consumers under the age of 18, a demographic particularly vulnerable to the potential adverse health events cited in the filing. According to the allegations, these omissions rendered public statements made by the company materially false and misleading throughout the specified period.
Rosen Law Firm is currently organizing the class action and inviting affected investors to participate. Those who purchased stock during the class period may be eligible for compensation through a contingency fee arrangement, meaning no out-of-pocket costs for participants. Interested parties can contact Phillip Kim at 866-767-3653 or visit the firm's website to join. As no class has been certified yet, investors retain the right to select their own counsel or remain absent members while the case proceeds.

Comments (0)
No comments yet. Be the first!